Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2021-08-18
Summary
Multi-omics and Clinical Data Analysis is potential to predict the prognosis of lung cancer patients.
Conditions
- Lung Cancer
- Lung Adenocarcinoma
- Lung Squamous Cell Carcinoma
- Non Small Cell Lung Cancer
Sponsors & Collaborators
-
RenJi Hospital
lead OTHER
Principal Investigators
-
Huijing Huang · RenJi Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-07-01
- Primary Completion
- 2021-09-20
- Completion
- 2021-09-30
Countries
- China
Study Locations
More Related Trials
-
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
NCT05701787 ·Status: RECRUITING
-
Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.
NCT03397355 ·Status: UNKNOWN
-
Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer
NCT02941003 ·Status: UNKNOWN ·Phase: NA
-
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102 ·Status: RECRUITING
-
Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer
NCT03505515 ·Status: COMPLETED
-
Multi-dimensional Signatures for Precisely Predicting the Response and Prognosis of Lung Cancer Patients
NCT04980352 ·Status: UNKNOWN
-
Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer
NCT05979623 ·Status: COMPLETED
-
Integrative Analysis of Large-cell Lung Cancer
NCT02917369 ·Status: RECRUITING
-
A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer
NCT07026669 ·Status: RECRUITING
-
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
NCT06198868 ·Status: RECRUITING
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)
NCT04923802 ·Status: TERMINATED
-
Dynamic Monitoring Circulating Tumor DNA in Surgical Patients With Lung Cancer
NCT03317080 ·Status: UNKNOWN
-
Radiomics for prEdiction of lunG cAncer biologY
NCT05819905 ·Status: UNKNOWN
-
Combining Genomics and Imageomics to Predict the Sensitivity of Neoadjuvant Pemetrexed and Cisplatin Chemotherapy in Patients With Lung Adenocarcinoma
NCT05185544 ·Status: UNKNOWN
-
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
NCT06255197 ·Status: RECRUITING
-
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
NCT06617390 ·Status: COMPLETED
-
Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
NCT06699979 ·Status: RECRUITING
-
A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer
NCT06405815 ·Status: COMPLETED
-
The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer
NCT05541744 ·Status: RECRUITING
-
Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy
NCT05636605 ·Status: RECRUITING
-
CTC in Lung Caner Patients With Bone Metastases
NCT04568291 ·Status: UNKNOWN ·Phase: NA
-
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer
NCT05425134 ·Status: UNKNOWN
-
A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer
NCT00958555 ·Status: UNKNOWN